In vitro-binding of the natural siderophore enantiomers pyochelin and enantiopyochelin to their AraC-type regulators PchR in Pseudomonas.

Détails

Ressource 1Télécharger: REF.pdf (248.09 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_96BF5150B68E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
In vitro-binding of the natural siderophore enantiomers pyochelin and enantiopyochelin to their AraC-type regulators PchR in Pseudomonas.
Périodique
Biometals
Auteur⸱e⸱s
Lin P.C., Youard Z.A., Reimmann C.
ISSN
1572-8773 (Electronic)
ISSN-L
0966-0844
Statut éditorial
Publié
Date de publication
2013
Volume
26
Numéro
6
Pages
1067-1073
Langue
anglais
Résumé
The enantiomeric siderophores pyochelin and enantiopyochelin of Pseudomonas aeruginosa and Pseudomonas protegens promote growth under iron limitation and activate transcription of their biosynthesis and uptake genes via the AraC-type regulator PchR. Here we investigated siderophore binding to PchR in vitro using fluorescence spectroscopy. A fusion of the N-terminal domain of P. aeruginosa PchR with maltose binding protein (MBP-PchR'PAO) bound iron-loaded (ferri-) pyochelin with an affinity (Kd) of 41 ± 5 μM. By contrast, no binding occurred with ferri-enantiopyochelin. Stereospecificity of a similar fusion protein of the P. protegens PchR (MBP-PchR'CHA0) was less pronounced. The Kd's of MBP-PchR'CHA0 for ferri-enantiopyochelin and ferri-pyochelin were 24 ± 5 and 40 ± 7 μM, respectively. None of the proteins interacted with the iron-free siderophore enantiomers, suggesting that transcriptional activation by PchR occurs only when the respective siderophore actively procures iron to the cell.
Mots-clé
Siderophore, Pseudomonas, Iron, Pyochelin, AraC-type regulator
Pubmed
Web of science
Open Access
Oui
Création de la notice
12/12/2013 12:13
Dernière modification de la notice
14/02/2022 8:56
Données d'usage